This review will discuss the basic concepts concerning the use of cell‐targeting peptides (CTPs) and cell‐penetrating peptides (CPPs) in the context of nanocarrier technology. It deals with the discovery and subsequent evolution of CTPs and CPPs, issues concerning their interactions with cells and their biodistribution in vivo , and their potential advantages and disadvantages as delivery agents. The article also briefly discusses several specific examples of the use of CTPs or CPPs to assist in the delivery of nanoparticles, liposomes, and other nanocarriers.
No takes yet. Share an insight, caveat, or question.
Juliano et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology